Prohost Biotech - Exclusive Biotech Research - A Comprehensive Resource for Biotech News

Atara Allogeneic Product ATA188 Will Confirm Whether EBV Infecting B Cells Could Cause a Difficult to Treat Kind of MS

September 17, 2019 0

Atara Biotherapeutics ATA188 for MS Atara Biotherapeutics (ATRA) announced the presentation of initial efficacy data as …

Why Alder Biopharmaceuticals Stock Gained Over 83%. See Also: Prohost Picked Stocks Outperforming in a Down Market Day

September 16, 2019 0

Migraine's Really Effective Treatments The years 2018 and 2019 could be called the years of migraine’s …

Moderna Therapeutics: A Big Day Filled with Good News

September 13, 2019 0

Moderna Therapeutics Trial Results Moderna Therapeutics (MRNA) trial results mark the first systemic mRNA therapeutic to …

About RegenxBio’s Agreement with Clearside Biomedical and More

September 10, 2019 0

Diseases of the Back of the Eye Diseases of the back of the eye, such as: age-related …

Amgen’s Oncology Product AMG-510 Meeting An Unmet Need for Kras G12C Mutated Cancers

September 9, 2019 0

Amgen's Outperforming After being boxed in, for the past couple of weeks, Amgen’s (AMGN) stock finally outperformed. …

Vertex: In Pursuit of Cures

September 4, 2019 0

Vertex Pharmaceuticals Is Acquiring Semma Therapeutics Vertex Pharmaceutical (VRTX) entered into a definitive agreement to buy a …

Outperforming Biotechs In a Bad Market Day

September 3, 2019 0

Outperforming Biotechs On August 27, 2019 we posted “The Medicines Company Has Agreeable News” under Today’s …

Gene Therapy and Other Treatments That Work at the Genetic Level

August 30, 2019 0

Gene Therapy Stocks Experiencing Selloffs Every investor in the biotech sector must have experienced selloffs of …

The Medicines Company Has Agreeable News

August 27, 2019 0

The Medicines Company The Medicines Company (MDCO) focuses on cardiovascular diseases. Major goals are halting the …

Amgen to Acquire Celgene’s Product Otezla at $13.4 Billion

August 26, 2019 0

Amgen Agreement with Celgene for Otezla® In the News Amgen (AMGN) entered into an agreement with …

AstraZeneca and Vertex Both Have Good News

August 21, 2019 0

AstraZeneca: Farxiga for Heart Failure with Reduced Ejection Fraction AstraZeneca (AZN) has good news. Many of them …

Moderna’s Investigational Zika Vaccine Is Granted FDA Fast Track Designation

August 20, 2019 0

From Moderna From the press release we learned that the U.S. Food and Drug Administration (FDA) …

The Bizarre Market

August 20, 2019 0

The Week in Review #41 We Are Still Witnessing … The bizarre market performance that started …

Why Akari Therapeutics Stock Price Rallied Today

August 14, 2019 0

Akari Therapeutics Stock Rallied Autoimmune and inflammatory disease treatments are works in progress with some approved …

Regeneron: Successful Cure for Ebola-Infected People. Read Also: The Midday Outperforming Biotech Stocks

August 13, 2019 0

Regeneron Product REGN-EB3 Saving Lives Regeneron (REGN) announced that an independent monitoring board ended its investigational product …

A Press Release About Regeneron Product REGN-EB3 Showing Superiority in Preventing Ebola Deaths

August 13, 2019 0

Palm Ebola Clinical Trial Stopped Early as Regeneron Product REGN-EB3 Therapy Shows Superiority to ZMapp in …

The Value of the Biotech Companies

August 12, 2019 0

Prohost Letter #434 Special Issue The Value of the Biotech Companies With a strong economy and …

Why Amgen’s Stock Is Up Over $11 Today

August 9, 2019 0

Amgen’s Stock Is Up Amgen (AMGN) is speeding towards reaching its true, fair value. In the Q2 …

Court Upholds Validity of Amgen’s Claims Regarding Enbrel

August 9, 2019 0

Press Release Amgen Wins Patent Case On Enbrel® (etanercept) Court Upholds Validity of Patent Claims Directed …

Nektar’s Story Has Nothing to Do with the Efficacy Or the Value of NKTR-214

August 9, 2019 2

Nektar Therapeutics Story Everything was going well with Nektar Therapeutics (NKTR) stock during the Conference call …

Exclusive Market Insight

& Scientific analysis

Latest Articlesddd

Atara Allogeneic Product ATA188 Will Confirm Whether EBV Infecting B Cells Could Cause a Difficult to Treat Kind of MS

Why Alder Biopharmaceuticals Stock Gained Over 83%. See Also: Prohost Picked Stocks Outperforming in a Down Market Day

Moderna Therapeutics: A Big Day Filled with Good News

About RegenxBio’s Agreement with Clearside Biomedical and More

Amgen’s Oncology Product AMG-510 Meeting An Unmet Need for Kras G12C Mutated Cancers

Vertex: In Pursuit of Cures

Outperforming Biotechs In a Bad Market Day

Gene Therapy and Other Treatments That Work at the Genetic Level

The Medicines Company Has Agreeable News

Amgen to Acquire Celgene’s Product Otezla at $13.4 Billion

AstraZeneca and Vertex Both Have Good News

Moderna’s Investigational Zika Vaccine Is Granted FDA Fast Track Designation

The Bizarre Market

Why Akari Therapeutics Stock Price Rallied Today

Regeneron: Successful Cure for Ebola-Infected People. Read Also: The Midday Outperforming Biotech Stocks

A Press Release About Regeneron Product REGN-EB3 Showing Superiority in Preventing Ebola Deaths

The Value of the Biotech Companies

Why Amgen’s Stock Is Up Over $11 Today

Court Upholds Validity of Amgen’s Claims Regarding Enbrel

Nektar’s Story Has Nothing to Do with the Efficacy Or the Value of NKTR-214